The Role of APO‐1‐Mediated Apoptosis in the Immune System
Peter H. Krammer(Slovak Academy of Sciences), Klaus‐Michael Debativ(German Cancer Research Center), Stefan Hellbardt(German Cancer Research Center), Michael O. Westendorp(German Cancer Research Center), Bernd Matiba(German Cancer Research Center), Sara M Mariani(German Cancer Research Center), Michael Fath(Heidelberg University), Iris Behrmann(University of Luxembourg), Jens Dhein(German Cancer Research Center), Marcus E. Peter(Northwestern University), Matthias Germer(German Cancer Research Center), Henning Walczak(CRUK Lung Cancer Centre of Excellence), Caroline Bäumler(University Hospital Heidelberg), Eckart Knipping(German Cancer Research Center), Peter T. Daniel(Charité - Universitätsmedizin Berlin), Kirstin Stricker(German Cancer Research Center)
Cited by 234
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
|Genes & Development|2008|2.3k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k